1. Corporate Officers - B
2. Bedrosian Camille L

Insider Trading History of Bedrosian Camille L

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Bedrosian Camille L since 2020. This trader's CIK number is 1326969. At the time of last reporting, Bedrosian Camille L was the Chief Medical Officer of Amylyx Pharmaceuticals, Inc.. (stock ticker symbol AMLX). Also see all insider trading activities at Amylyx Pharmaceuticals, Inc..

Note that in the past Bedrosian Camille L also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Bedrosian Camille L

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	RYTM	0	$0	0	$0	4,000	$0
2024	RYTM	0	$0	0	$0	3,000	$0

Yearly summary of insider trading at Amylyx Pharmaceuticals, Inc. (AMLX) by Bedrosian Camille L

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	AMLX	0	$0	24,464	$218,593	0	$0
2024	AMLX	0	$0	16,863	$66,562	0	$0

Yearly summary of insider trading at Ultragenyx Pharmaceutical Inc. (RARE) by Bedrosian Camille L

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	RARE	0	$0	3,881	$175,615	0	$0
2022	RARE	0	$0	4,478	$297,794	0	$0
2021	RARE	0	$0	42,509	$5,538,557	35,000	$1,925,000
2020	RARE	0	$0	262	$23,056	0	$0

Insider trading activities at 3 companies by Bedrosian Camille L:

1. Rhythm Pharmaceuticals, Inc. (RYTM)

2. Amylyx Pharmaceuticals, Inc. (AMLX)

3. Ultragenyx Pharmaceutical Inc. (RARE)

Table 1. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Bedrosian Camille L

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-06-18	RYTM	Option Ex	4,000	.00	0
2024-06-21	RYTM	Option Ex	3,000	.00	0

Table 2. Insider trading of Amylyx Pharmaceuticals, Inc. (AMLX) by Bedrosian Camille L

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-09-30	AMLX	Sale	12,039	14.58	175,516
2025-03-31	AMLX	Sale	12,425	3.47	43,077
2024-12-02	AMLX	Sale	5,421	5.54	30,005
2024-09-30	AMLX	Sale	11,442	3.19	36,557

Table 3. Insider trading of Ultragenyx Pharmaceutical Inc. (RARE) by Bedrosian Camille L

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-03-01	RARE	Sale	3,881	45.25	175,615
2022-03-01	RARE	Sale	2,821	66.62	187,935
2022-01-30	RARE	Sale	1,657	66.30	109,859
2021-10-14	RARE	Sale	359	81.14	29,129
2021-09-01	RARE	Option Ex	2,500	55.00	137,500
2021-09-02	RARE	Option Ex	2,500	55.00	137,500
2021-09-01	RARE	Sale	2,500	100.03	250,075
2021-09-02	RARE	Sale	2,500	100.18	250,450
2021-05-06	RARE	Sale	364	113.67	41,375
2021-04-15	RARE	Sale	5,000	109.09	545,450
2021-04-15	RARE	Option Ex	5,000	55.00	275,000
2021-03-01	RARE	Sale	4,543	138.18	627,751
2021-01-30	RARE	Sale	2,243	140.36	314,827
2021-01-15	RARE	Option Ex	25,000	55.00	1,375,000
2021-01-15	RARE	Sale	25,000	139.18	3,479,500
2020-10-14	RARE	Sale	262	88.00	23,056

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bedrosian Camille L (Chief Medical Officer of Amylyx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month